COGNEX CORP (CGNX) Spending and interest coverage
- R&D / revenue · 12 months: Value 12.91%; Formula and calculation Research and development expense / revenue. Period ending 2026-07-05..
- Stock-based compensation / revenue · 12 months: Value (m); Formula and calculation Share-based compensation / revenue. Period ending 2026-07-05..
- Interest coverage · 12 months: Value (m); Formula and calculation Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified..
Spending and interest coverage
Overview →Financial period ending 2026-07-05; current quote (m). Amounts retain their stated periods and units.
| Metric | Value | Formula and calculation |
|---|---|---|
| R&D / revenue · 12 months | 12.91% | Research and development expense / revenue. Period ending 2026-07-05. $140.56M ÷ $1.09B × 100 ≈ 12.91% |
| Stock-based compensation / revenue · 12 months | (m) | Share-based compensation / revenue. Period ending 2026-07-05. Calculation unavailable: missing inputs remain (m). |
| Interest coverage · 12 months | (m) | Estimated: average term debt × dated USD coupon proxy + average commercial paper × matching-currency disclosed rate at or before period end. Swaps, foreign-exchange, lease interest and amortization are not quantified. Calculation unavailable: missing inputs remain (m). |
Calculation inputs
| Input | Amount with unit | Raw financial data |
|---|---|---|
| Research and development spending | 140.56M USD | Research and Development Expense |
| Revenue | 1.09B USD | Revenue from Contract with Customer, Excluding Assessed Tax |
| Stock-based compensation | (m) | Share-based Payment Arrangement, Noncash Expense |
| Operating income | 238.43M USD | Operating Income (Loss) |
| Interest expense · reported / estimated | (m) | · Estimated expense assumptions |
Latest interest expense basis: (m). Estimated values carry *; expand each history row’s basis for its dated balances and rate assumptions.
Calculated history
Changes compare with the next older row (previous quarter), unless explicitly labeled otherwise. Rolling 12-month growth compares two successive quarter-end rolling totals; it is not year-over-year growth.
| Period ending | Research and development spending (USD) | Revenue (USD) | Stock-based compensation (USD) | Operating income (USD) | Interest expense · reported / estimated (USD) | R&D / revenue | SBC / revenue | Interest coverage | Interest expense basis |
|---|---|---|---|---|---|---|---|---|---|
| 2026-07-05 | $140.56M | $1.09B | (m) | $238.43M | (m) | 12.91% | (m) | (m) | (m) |
| 2026-04-05 | $141.27M | $1.05B | (m) | $196.35M | (m) | 13.50% | (m) | (m) | (m) |
| 2025-12-31 | $138.97M | $994.36M | (m) | $162.57M | (m) | 13.98% | (m) | (m) | (m) |
| 2025-09-28 | $135.45M | $971.71M | (m) | $158.13M | (m) | 13.94% | (m) | (m) | (m) |
| 2025-06-29 | $135.58M | $929.55M | (m) | $131.93M | (m) | 14.59% | (m) | (m) | (m) |
| 2025-03-30 | $137.44M | $919.75M | (m) | $126.95M | (m) | 14.94% | (m) | (m) | (m) |
| 2024-12-31 | $139.81M | $914.51M | (m) | $115.06M | (m) | 15.29% | (m) | (m) | (m) |
| 2024-09-29 | $141.97M | $881.50M | (m) | $96.95M | (m) | 16.11% | (m) | (m) | (m) |
| 2024-06-30 | $139.34M | $844.00M | (m) | $96.03M | (m) | 16.51% | (m) | (m) | (m) |
| 2024-03-31 | $137.96M | $847.22M | (m) | $122.75M | (m) | 16.28% | (m) | (m) | (m) |
| 2023-12-31 | $139.40M | $837.55M | (m) | $130.70M | (m) | 16.64% | (m) | (m) | (m) |
| 2023-10-01 | $141.84M | $880.31M | (m) | $172.31M | (m) | 16.11% | (m) | (m) | (m) |
| 2023-07-02 | $143.22M | $892.69M | (m) | $181.70M | (m) | 16.04% | (m) | (m) | (m) |
| 2023-04-02 | $143.62M | $924.81M | (m) | $181.66M | (m) | 15.53% | (m) | (m) | (m) |
| 2022-12-31 | $141.13M | $1.01B | (m) | $246.23M | (m) | 14.03% | (m) | (m) | (m) |
| 2022-10-02 | $139.49M | $1.01B | (m) | $248.41M | (m) | 13.80% | (m) | (m) | (m) |
| 2022-07-03 | $140.01M | $1.09B | (m) | $295.94M | (m) | 12.89% | (m) | (m) | (m) |
| 2022-04-03 | $137.32M | $1.08B | (m) | $323.38M | (m) | 12.71% | (m) | (m) | (m) |
| 2021-12-31 | $135.37M | $1.04B | (m) | $315.10M | (m) | 13.05% | (m) | (m) | (m) |
| 2021-10-03 | $134.28M | $1.02B | (m) | $317.67M | (m) | 13.21% | (m) | (m) | (m) |
| 2021-07-04 | $130.05M | $982.87M | (m) | $326.75M | (m) | 13.23% | (m) | (m) | (m) |
| 2021-04-04 | $129.14M | $882.81M | (m) | $228.03M | (m) | 14.63% | (m) | (m) | (m) |
| 2020-12-31 | $130.98M | $811.02M | $1.40M | $170.53M | (m) | 16.15% | 0.17% | (m) | (m) |
| 2020-09-27 | $129.57M | $757.17M | (m) | $129.05M | (m) | 17.11% | (m) | (m) | (m) |
| 2020-06-28 | $127.45M | $689.43M | (m) | $75.51M | (m) | 18.49% | (m) | (m) | (m) |
| 2020-03-29 | $125.13M | $719.38M | (m) | $133.41M | (m) | 17.39% | (m) | (m) | (m) |
| 2019-12-31 | $119.43M | $725.63M | (m) | $142.60M | (m) | 16.46% | (m) | (m) | (m) |
| 2019-09-29 | $115.22M | $749.14M | (m) | $170.24M | (m) | 15.38% | (m) | (m) | (m) |
| 2019-06-30 | $116.80M | $798.04M | (m) | $204.99M | (m) | 14.64% | (m) | (m) | (m) |
| 2019-03-31 | $115.61M | $810.25M | (m) | $216.69M | (m) | 14.27% | (m) | (m) | (m) |
| 2018-12-31 | $116.44M | $806.34M | (m) | $221.14M | (m) | 14.44% | (m) | (m) | (m) |
| 2018-09-30 | $114.64M | $777.84M | (m) | $227.13M | (m) | 14.74% | (m) | (m) | (m) |
| 2018-07-01 | $111.02M | $811.66M | (m) | $260.13M | (m) | 13.68% | (m) | (m) | (m) |
| 2018-04-01 | $107.51M | $778.48M | (m) | $256.70M | (m) | 13.81% | (m) | (m) | (m) |
| 2017-12-31 | $99.20M | $747.95M | (m) | $259.32M | (m) | 13.26% | (m) | (m) | (m) |
| 2017-10-01 | $91.67M | $696.91M | (m) | $247.45M | (m) | 13.15% | (m) | (m) | (m) |
| 2017-07-02 | $84.19M | $585.12M | (m) | $191.73M | (m) | 14.39% | (m) | (m) | (m) |
| 2017-04-02 | $80.48M | $559.49M | (m) | $181.87M | (m) | 14.39% | (m) | (m) | (m) |
| 2016-12-31 | $78.27M | $520.75M | (m) | $160.78M | (m) | 15.03% | (m) | (m) | (m) |
| 2016-10-02 | $76.36M | $489.20M | (m) | $139.69M | (m) | 15.61% | (m) | (m) | (m) |
| 2016-07-03 | $74.73M | $448.83M | (m) | $113.65M | (m) | 16.65% | (m) | (m) | (m) |
| 2016-04-03 | $73.36M | $445.39M | (m) | $115.75M | (m) | 16.47% | (m) | (m) | (m) |
| 2015-12-31 | $69.79M | $450.56M | (m) | $121.52M | (m) | 15.49% | (m) | (m) | (m) |
| 2015-10-04 | $70.56M | $511.11M | (m) | $143.27M | (m) | 13.81% | (m) | (m) | (m) |
| 2015-07-05 | $71.11M | $557.88M | (m) | $170.13M | (m) | 12.75% | (m) | (m) | (m) |
| 2015-04-05 | $65.49M | $508.77M | (m) | $145.14M | (m) | 12.87% | (m) | (m) | (m) |
| 2014-12-31 | $59.92M | $486.27M | (m) | $143.66M | (m) | 12.32% | (m) | (m) | (m) |
| 2014-09-28 | $57.36M | $464.78M | (m) | $137.43M | (m) | 12.34% | (m) | (m) | (m) |
| 2014-06-29 | $51.00M | $386.21M | (m) | $101.38M | (m) | 13.21% | (m) | (m) | (m) |
| 2014-03-30 | $49.27M | $363.92M | (m) | $90.83M | (m) | 13.54% | (m) | (m) | (m) |
| 2013-12-31 | $48.09M | $353.89M | (m) | $86.37M | (m) | 13.59% | (m) | (m) | (m) |
| 2013-09-29 | $46.28M | $340.36M | (m) | $82.05M | (m) | 13.60% | (m) | (m) | (m) |
| 2013-06-30 | $44.10M | $329.65M | (m) | $80.47M | (m) | 13.38% | (m) | (m) | (m) |
| 2013-03-31 | $42.51M | $327.46M | (m) | $83.65M | (m) | 12.98% | (m) | (m) | (m) |
| 2012-12-31 | $41.55M | $324.28M | (m) | $83.41M | (m) | 12.81% | (m) | (m) | (m) |
| 2012-09-30 | $41.01M | $326.15M | (m) | $84.45M | (m) | 12.57% | (m) | (m) | (m) |
| 2012-07-01 | $41.62M | $326.16M | (m) | $85.04M | (m) | 12.76% | (m) | (m) | (m) |
| 2012-04-01 | $41.83M | $325.23M | (m) | $85.73M | (m) | 12.86% | (m) | (m) | (m) |
| 2011-12-31 | $40.95M | $321.91M | (m) | $85.36M | (m) | 12.72% | (m) | (m) | (m) |
| 2011-10-02 | $39.54M | $322.79M | (m) | $86.74M | (m) | 12.25% | (m) | (m) | (m) |
| 2011-07-03 | $36.89M | $317.70M | (m) | $86.63M | (m) | 11.61% | (m) | (m) | (m) |
| 2011-04-03 | $34.46M | $306.12M | (m) | $81.83M | (m) | 11.26% | (m) | (m) | (m) |
| 2010-12-31 | $33.08M | $290.69M | (m) | $75.71M | (m) | 11.38% | (m) | (m) | (m) |
| 2010-10-03 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-07-04 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-04-04 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-12-31 | $31.13M | $175.73M | (m) | $-12.67M | (m) | 17.72% | (m) | (m) | (m) |
| 2009-10-04 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2009-07-05 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2008-12-31 | $36.26M | $242.68M | (m) | $25.10M | (m) | 14.94% | (m) | (m) | (m) |
(m) means missing inputs. Historical market-based ratios use the saved close on or immediately before period ending and that period’s reported shares; current quotes are not substituted. Five-year projections repeat historical CAGR, not analyst forecasts.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Ralliant Corp (RAL) | United States | $7.737B | -6.14 |
| Sensata Technologies Holding plc (ST) | $5.976B | 77.15 | |
| Fortive Corp (FTV) | United States | $16.897B | 31.51 |
| MKS INC (MKSI) | United States | $17.440B | 68.37 |
| MESA LABORATORIES INC /CO/ (MLAB) | United States | $0.768B | 116.22 |
| Senseonics Holdings, Inc. (SENS) | United States | $0.546B | -2.74 |
| HURCO COMPANIES INC (HURC) | United States | $0.140B | -20.39 |
| SYPRIS SOLUTIONS INC (SYPR) | United States | $0.040B | -4.94 |
| ClearSign Technologies Corp (CLIR) | United States | $0.024B | -4.54 |
| FOCUS UNIVERSAL INC. (FCUV) | United States | $0.003B | -0.58 |